Integrative Weaning Index: A Few Observations

A. Ray

DOI: https://doi.org/10.4103/0972-5229.218154

2017-11-01

Indian Journal of Critical Care Medicine

Abstract:

What problem does this paper attempt to address?

Cord blood and breast-milk antibodies in neonatal rotavirus infection

B M Totterdell,I L Chrystie,J E Banatvala

DOI: https://doi.org/10.1136/bmj.280.6217.828

1980-03-22

Abstract:Studies were carried out during an outbreak of rotavirus type 2 infection in a neonatal nursery to determine the protective role of antibodies in cord blood and breast milk. The range, distribution, and geometric mean titres of rotavirus-specific antibody in the cord blood were similar among rotavirus-positive and rotavirus-negative neonates, and the amount of virus excreted did not correlate with antibody levels. Despite the protective effect of breast feeding, the pattern of rotavirus-specific IgA and IgG antibodies in the expressed breast milk of mothers of babies who were rotavirus excreters and non-excreters was similar. Nevertheless, a higher proportion of expressed breast milk samples contained rotavirus-specific IgA group 2 (92%) and type 2 (97%) specific antibodies than type I (67%) antibodies, and the geometric mean titres of group 2 and type 2 specific antibodies were tenfold higher than type I antibodies. Among breast-fed babies who excreted rotavirus there was no correlation between type 2 rotavirus-specific IgA antibodies in expressed breast milk and the amount of neonatal virus excretion. These studies suggest that factors other than the rotavirus antibodies in expressed breast milk are of importance in preventing rotavirus infection in newborn infants.
Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors

S Jayashree,M K Bhan,R Kumar,N Bhandari,S Sazawal

DOI: https://doi.org/10.1002/jmv.1890260313

Abstract:The role of breast milk antirotavirus immunoglobulin A (IgA) and trypsin inhibitors in limiting the acquisition of rotavirus infection during the initial 5 days of life was evaluated among 42 exclusively breast-fed hospital-born infants, 22 of whom experienced rotavirus infection. The mean concentrations of antirotavirus IgA (ELISA Units) in the breast milk of mothers of the 22 rotavirus-infected neonates was 130.4 +/- 46.4; the corresponding value in 20 noninfected neonates was 384.3 +/- 328.3 (P less than 0.001). Similarly, the trypsin inhibitory capacity (mumols/mt/ml) of breast milk in the rotavirus-infected group was significantly lower (0.109 +/- 0.095) than that in the noninfected group (0.376 +/- 0.191; P less than 0.001). The trypsin inhibitory capacity of milk showed an inverse correlation with infant stool tryptic activity (P less than 0.01). Our results indicate that the acquisition of rotavirus infection during the early neonatal period depends on the concentrations of antirotavirus IgA and trypsin inhibitors in human milk and that protection is mediated by high levels of these antiviral factors.
Pyrin Levels in Human Monocytes and Monocyte-Derived Macrophages Regulate IL-1β Processing and Release1

S. Seshadri,M. Duncan,J. Hart,M. Gavrilin,M. Wewers

DOI: https://doi.org/10.4049/jimmunol.179.2.1274

2007-04-01

Abstract:Macrophages and their precursors, monocytes, are key cells involved in the innate immune response. Although both monocytes and macrophages produce caspase-1, the key enzyme responsible for pro-IL-1β processing; macrophages are limited in their ability to activate the enzyme and release functional IL-1β. In this context, because mutations in the pyrin gene (MEFV) cause the inflammatory disorder familial Mediterranean fever, pyrin is believed to regulate IL-1β processing. To determine whether variations in pyrin expression explain the difference between monocytes and macrophages in IL-1β processing and release, pyrin was studied in human monocytes and monocyte-derived macrophages. Although monocytes express pyrin mRNA and protein, which is readily inducible by endotoxin, monocyte-derived macrophages express significantly less pyrin mRNA and protein. Pyrin levels directly correlated with IL-1β processing in monocytes and macrophages; therefore, we asked whether pyrin might promote IL-1β processing and release. HEK293 cells were transfected with pyrin, caspase-1, apoptotic speck protein with a caspase recruitment domain, and IL-1β. Pyrin induced IL-1β processing and release in a dose-dependent manner. Conversely, pyrin small interference RNA suppressed pro-IL-1β processing in both THP-1 cells and fresh human monocytes. In summary, both pyrin expression and IL-1β processing and release are diminished upon the maturation of monocytes to macrophages. When pyrin is ectopically expressed or silenced, IL-1β processing and release parallels the level of pyrin. In conclusion, in the context of endotoxin-induced activation of mononuclear phagocytes, pyrin augments IL-1β processing and release.
Neutralizing activity and secretory IgA antibodies reactive with rotavirus SA-11 (serotype G3) in colostrum and milk from Brazilian women

M Tino De Franco,P D Vieira,S M R Santos,T L Ferreira,E D Araújo,V S Quintal,S B Carbonare

DOI: https://doi.org/10.1179/2046905513Y.0000000057

Abstract:Background: Rotavirus is an important aetiological agent for severe diarrhoea in infants and young children worldwide. Anti-rotavirus antibodies in human colostrum and milk may interfere with rotavirus vaccination seroconversion. Aims: To verify the presence of anti-rotavirus secretory IgA antibodies (SIgA) and the neutralizing capacity of 30 colostrum and 30 milk samples from Brazilian women in two different centres and analyze their persistence throughout lactation. Methods: Colostrum and milk samples from healthy nursing mothers were tested for the presence of anti-rotavirus SIgA using conventional ELISA and their capacity to neutralize rotavirus using MA-104 cell cultures. Total IgA concentrations and anti-rotavirus SIgA levels were measured in samples collected from three mothers during 90 or 240 days of the lactation period. Results: Colostrum samples showed higher levels of anti-rotavirus SIgA and higher neutralizing ability than in milk. However, these antibodies levels were not statistically different. In addition, there was no correlation between antibody levels and the neutralizing activity observed in colostrum and milk samples. Follow-up of three mothers demonstrated the persistence of anti-rotavirus and total IgA levels throughout lactation. Conclusions: These results support the encouragement of breastfeeding as a mechanism of protection against rotavirus infection in lactating infants. Components other than SIgA antibodies might play an important role in virus neutralization.
Rotavirus infections in young Nicaraguan children

F Espinoza,M Paniagua,H Hallander,L Svensson,O Strannegård

DOI: https://doi.org/10.1097/00006454-199706000-00006

Abstract:Background: Rotavirus is an important cause of dehydrating diarrhea in young children throughout the world. Knowledge about frequency of reinfections, development of immunity to the virus and the possible protective effect of breast milk is important, in particular in relation to possible strategies for immunization. Methods: A prospective study of rotavirus infections in a cohort of 235 infants followed from birth until 2 years of age was performed in León, Nicaragua. Fecal and serum specimens were collected at specified times, and stools were also obtained during episodes of diarrhea. Fecal specimens were screened by rotavirus antigen detection and serum and colostral specimens were analyzed by isotype-specific rotavirus antibody enzyme-linked immunosorbent assay. Results: As judged by anti-rotavirus IgA antibody seroconversion and/or demonstration of rotavirus antigen in fecal specimens, > 50% of the babies had evidence of past rotavirus infection by the age of 2 months. The total incidence of rotavirus infections, including many reinfections, was 0.7 infection/child-year, of which only 17% were associated with diarrhea. The time from birth to the first demonstration of rotavirus in stool samples correlated significantly with the concentration of anti-rotavirus IgA antibodies in colostrum. There was also a tendency toward a relationship between long duration of breast-feeding and asymptomatic infection. Conclusions: Rotavirus infections are acquired very early in infants in León, Nicaragua, and reinfections are common. Most infections are asymptomatic. Breast milk appears to confer partial protection against rotavirus infection, probably mediated by specific IgA antibodies. To be effective rotavirus vaccination would probably have to be given at a very early age to infants in developing countries.
Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies.

V Parre O,D C Hodgins,L de Arriba,S Y Kang,L Yuan,L A Ward,T L T,L J Saif,V Parre√±o,T L T√¥

DOI: https://doi.org/10.1099/0022-1317-80-6-1417

1999-06-01

Journal of General Virology

Abstract:The effects of passive antibodies on protection and active immune responses to human rotavirus were studied in gnotobiotic pigs. Pigs were injected at birth with saline or sow serum of high (immunized) or low (control) antibody titre and subsets of pigs were fed colostrum and milk from immunized or control sows. Pigs were inoculated at 3-5 days of age and challenged at 21 days post-inoculation (p.i.) with virulent Wa human rotavirus. Pigs receiving immune serum with or without immune colostrum/milk were partially protected against diarrhoea and virus shedding after inoculation, but had significantly lower IgA antibody titres in serum and small intestinal contents at 21 days p.i. and lower protection rates after challenge compared with pigs given control or no maternal antibodies. IgG antibody titres were consistently higher in small than in large intestinal contents. Pigs given control serum with control colostrum/milk had lower rates of virus shedding after inoculation than those given control serum alone. In summary, high titres of circulating maternal antibodies with or without local (milk) antibodies provided passive protection after inoculation but suppressed active mucosal antibody responses. These findings may have implications for the use of live, oral rotavirus vaccines in breast-fed infants.

biotechnology & applied microbiology,virology
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi

Benjamin Morgan,Eleanor A. Lyons,Amanda Handley,Nada Bogdanovic-Sakran,Daniel Pavlic,Desiree Witte,Jonathan Mandolo,Ann Turner,Khuzwayo C. Jere,Frances Justice,Darren Suryawijaya Ong,Rhian Bonnici,Karen Boniface,Celeste M. Donato,Ashley Mpakiza,Anell Meyer,Naor Bar-Zeev,Miren Iturriza-Gomara,Nigel A. Cunliffe,Margaret Danchin,Julie E. Bines

DOI: https://doi.org/10.3390/v16091488

2024-09-20

Viruses

Abstract:High titres of rotavirus-specific maternal antibodies may contribute to lower rotavirus vaccine efficacy in low- and middle-income countries (LMICs). RV3-BB vaccine (G3P[6]) is based on a neonatal rotavirus strain that replicates well in the newborn gut in the presence of breast milk. This study investigated the association between maternal serum antibodies and vaccine response in infants administered the RV3-BB vaccine. Serum was collected antenatally from mothers of 561 infants enrolled in the RV3-BB Phase II study conducted in Blantyre, Malawi, and analysed for rotavirus-specific serum IgA and IgG antibodies using enzyme-linked immunosorbent assay. Infant vaccine take was defined as cumulative IgA seroconversion (≥3 fold increase) and/or stool vaccine shedding. Maternal IgA or IgG antibody titres did not have a negative impact on vaccine-like stool shedding at any timepoint. Maternal IgG (but not IgA) titres were associated with reduced take post dose 1 (p < 0.005) and 3 (p < 0.05) in the neonatal vaccine schedule group but not at study completion (week 18). In LMICs where high maternal antibodies are associated with low rotavirus vaccine efficacy, RV3-BB in a neonatal or infant vaccine schedule has the potential to provide protection against severe rotavirus disease.

virology
Viraemia and Extraintestinal Involvement after Rotavirus Infection

Xiao-Lei Huang,Jie Chen,Yan-Ping Yu,Li-Qin Chen,Zhong-Yue Li,Zheng-Yan Zhao

DOI: https://doi.org/10.3785/j.issn.1008-9292.2006.01.013

2006-01-01

Abstract:OBJECTIVE:To study the incidence of viraemia and extraintestinal organ damage in children with acute rotavirus (RV) gastroenteritis.METHODS:Eighty-three children with acute rotavirus gastroenteritis were hospitalized from October 2002 to March 2003, whose blood and fecal samples were obtained on admission. Rotavirus RNA (encoding the VP7 outer capsid protein) were detected in blood and fecal samples by nest reverse transcription-polymerase chain reaction (RT-PCR). According to the result of blood RV-RNA, the patients were divided into RV-RNA positive group and RV-RNA negative group. The differences between these two groups in the severity of gastroenteritis and extraintestinal organ damage were analyzed.RESULTS:Eighty-two of 83 stool samples from the children with rotavirus infection were positive for rotavirus RNA. Sixteen of 83 blood samples were positive for rotavirus RNA with a positive rate of 19.3%. The nucleotide sequence of cloned cDNAs, resembling part of the VP7 gene, was identical from paired blood and fecal samples. There were no significant differences between blood RV-RNA positive group and blood RV-RNA negative group in the rate and degree of fever, diarrhea, dehydration, metabolic acidosis, hypokalemia and myocardial damage (P>0.05); while the incidences of liver damage, rash, lower respiratory tract infection and the central nervous system involvement in the blood RV-RNA positive group were significantly higher than those in the blood RV-RNA negative group (P<0.05).CONCLUSION:Viraemia is present in the children with acute rotavirus gastroenteritis. Viraemia might be an important mechanism by which rotavirus spread to the extraintestinal sites resulting in organs damage.
Acetylcholinesterase inhibitors: a patent review (2008 – present)

M. Pohanka

DOI: https://doi.org/10.1517/13543776.2012.701620

2012-07-20

Expert Opinion on Therapeutic Patents

Abstract:Introduction: Both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are present in the body in large amounts. AChE is an important part of the cholinergic nervous system taking place in the central and peripheral nervous system. AChE is a target of several toxins such as insecticide carbofuran, nerve agents, sarin, soman, tabun and VX. Beside toxins, drugs for treatment of Alzheimer's disease and myasthenia gravis, such as galantamine, donepezil, rivastigmine, tacrine, huperzine, pyridostigmine and neostigmine, are known. Areas covered: The review gives an overview of the importance of the cholinergic nervous system, the biochemistry of AChE and the role of AChE inhibitors. Current efforts to introduce potent drugs for Alzheimer's disease therapy and reduce toxicity, while keeping the maximal pharmacological effect, are also discussed. Expert opinion: The current research effort into AChE inhibitors can be divided into two categories. First, new toxins useful for agricultural purposes and second, novel drugs that need to be prepared, although there is less interest in the new toxins. The research for drugs for Alzheimer's disease needs to focus on inhibitors that reduce the deposition of amyloid plaques, but do not initiate AChE expression.
Maternal immunity protects offspring from enteric viral infection without negatively affecting humoral immune memory

Konjit Getachew Muleta Dr,Simone Isling Paerregaard Dr,Sharne Van Dijl,Asma Sadik Mustafa,Niklas Segren,Manar Alyamani Dr,Gina Lindberg,Joan Yuan Dr,Katharina Lahl Dr

DOI: https://doi.org/10.1101/2024.09.20.614185

2024-09-24

Abstract:Passive transfer of antibodies can effectively protect newborns from dysbiosis and infection but has also been proposed to inhibit intrinsic immune onset in the protected child. Yet, some early childhood vaccines are highly efficacious despite the presence of maternal antibodies. We here used a murine neonatal Rotavirus (RV) infection model in combination with cross-foster approaches to dissect the role that milk-derived antibodies play in the long-term induction of pup-intrinsic immunity. We found that milk-derived RV-specific antibodies efficiently protect from RV infection. While the occurrence of RV-specific IgA-producing plasma cells is temporarily blunted, maternally protected pups do mount delayed protective humoral immunity after weaning. Fate-mapping of pre-existing B cells revealed that the RV-specific plasma cell pool originates from B cells imprinted at the time of virus exposure regardless of maternal protection. Our data challenges the dogma that maternal antibody is inhibitory and instead permits safe and efficacious immune education in the growing organism.

Immunology
Rotavirus C: prevalence in suckling piglets and development of virus-like particles to assess the influence of maternal immunity on the disease development

Juliet Chepngeno,Annika Diaz,Francine C. Paim,Linda J. Saif,Anastasia N. Vlasova

DOI: https://doi.org/10.1186/s13567-019-0705-4

2019-10-22

Veterinary Research

Abstract:Abstract Rotavirus C (RVC) has been detected increasingly in humans and swine in different countries, including the US. It is associated with significant economic losses due to diarrheal disease in nursing piglets. In this study we aimed: (1) to determine the prevalence of RVC in healthy and diarrheic suckling piglets on US farms; and (2) to evaluate if maternal antibody (Ab) levels were associated with protection of newborn suckling piglets against RVC. There was a significantly higher prevalence ( p = 0.0002) of litters with diarrhea born to gilts compared with those born to multiparous sows. Of 113 nursing piglet fecal samples tested, 76.1% were RVC RNA positive. Fecal RVC RNA was detected in significantly ( p = 0.0419) higher quantities and more frequently in piglets with diarrhea compared with healthy ones (82.5 vs. 69.9%). With the exception of the historic strain Cowden (G1 genotype), field RVC strains do not replicate in cell culture, which is a major impediment for studying RVC pathogenesis and immunity. To circumvent this, we generated RVC virus-like particles (VLPs) for Cowden (G1), RV0104 (G3) and RV0143 (G6) and used them as antigens in ELISA to detect swine RVC Abs in serum and milk from the sows. Using RVC-VLP Ab ELISA we demonstrated that sows with diarrheic litters had significantly lower RVC IgA and IgG Ab titers in milk compared to those with healthy litters. Thus, our data suggest that insufficient lactogenic protection provided by gilts plays a key role in the development of and the increased prevalence of clinical RVC disease.

veterinary sciences
Bifidobacterium breve M-16 V and scGOS/lcFOS Supplementation to Dams Ameliorates Infant Rotavirus Infection in Early Life

Laura Sáez-Fuertes,Karla Rio-Aige,Malén Massot-Cladera,Margarida Castell,Karen Knipping,Johan Garssen,Raphaëlle Bourdet-Sicard,María José Rodríguez-Lagunas,María Carmen Collado,Francisco José Pérez-Cano

DOI: https://doi.org/10.1002/mnfr.202400377

Abstract:The immune system of newborns is underdeveloped, leaving them susceptible to infections like rotavirus (RV). Despite vaccines, RV remains a leading cause of child mortality, especially in developing countries. Maternal immunity is transferred during pregnancy and breastfeeding to the offspring providing protection against RV infection. This study aims to explore how the maternal diet can enhance the newborn's ability to fight early infections. Pregnant rats received orally Bifidobacterium breve M-16 V and short chain galacto-oligosaccharides (scGOS)/long chain fructo-oligosaccharides (lcFOS). At day 5 of life pups are infected with RV and at day 8, samples are collected for the infection analysis. Pups whose mothers received the synbiotic have lower RV infection severity. The levels of immunoglobulins (Ig) IgG2c and IgA are raised in pups' plasma and digested milk, respectively. Synbiotic supplementation improves intestinal maturation and increases gene expression of immune-related genes. In conclusion, the administration of this synbiotic to gestating and lactating mothers ameliorates the incidence and severity of the pup's diarrhea caused by the RV infection by improving their immunity.
Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection

Sasirekha Ramani,Christopher J. Stewart,Daniel R. Laucirica,Nadim J. Ajami,Bianca Robertson,Chloe A. Autran,Dhairyasheel Shinge,Sandya Rani,Sasirekha Anandan,Liya Hu,Josephine C. Ferreon,Kurien A. Kuruvilla,Joseph F. Petrosino,B. V. Venkataram Prasad,Lars Bode,Gagandeep Kang,Mary K. Estes

DOI: https://doi.org/10.1038/s41467-018-07476-4

IF: 16.6

2018-11-27

Nature Communications

Abstract:Neonatal rotavirus infections are predominantly asymptomatic. While an association with gastrointestinal symptoms has been described in some settings, factors influencing differences in clinical presentation are not well understood. Using multidisciplinary approaches, we show that a complex interplay between human milk oligosaccharides (HMOs), milk microbiome, and infant gut microbiome impacts neonatal rotavirus infections. Validating in vitro studies where HMOs are not decoy receptors for neonatal strain G10P[11], population studies show significantly higher levels of Lacto-N-tetraose (LNT), 2’-fucosyllactose (2’FL), and 6’-siallylactose (6’SL) in milk from mothers of rotavirus-positive neonates with gastrointestinal symptoms. Further, these HMOs correlate with abundance of Enterobacter/Klebsiella in maternal milk and infant stool. Specific HMOs also improve the infectivity of a neonatal strain-derived rotavirus vaccine. This study provides molecular and translational insight into host factors influencing neonatal rotavirus infections and identifies maternal components that could promote the performance of live, attenuated rotavirus vaccines.

multidisciplinary sciences
The Epidemiology of Rotavirus Infections

Ismail E. Haffejee

DOI: https://doi.org/10.1002/j.1536-4801.1995.tb11552.x

2024-01-04

Journal of Pediatric Gastroenterology and Nutrition

Abstract:Summary Rotavirus, which is the most common cause of infantile diarrhea worldwide, mainly affects infants between the ages of 6 and 24 months. Most infections in human newborns are mild or asymptomatic, due to the inherently attenuated nature of the "nursery" rotavirus strains. Adults are also sometimes affected, especially those in families with an infected child; the disease also occurs in closed adult communities, HIV‐infected persons, travelers, or as a result of water‐borne epidemics. Nosocomially acquired hospital infections add to morbidity and to the cost of hospitalization. A winter predominance of rotavirus diarrhea has been noted in temperate climates but not in tropical areas. Group A rotavirus infections are generally more common, but human infections with groups B and C have also been documented. The prevalence of scrum antibodies is high during the neonatal period, but it declines sharply between the ages of 3 and 6 months, then rises steeply, peaking at 2 years and remaining high into adulthood. Vaccines against rotavirus are currently under evaluation

pediatrics,gastroenterology & hepatology,nutrition & dietetics
Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants

Roma Chilengi,Michelo Simuyandi,Lauren Beach,Katayi Mwila,Sylvia Becker-Dreps,Devy M. Emperador,Daniel E. Velasquez,Samuel Bosomprah,Baoming Jiang

DOI: https://doi.org/10.1371/journal.pone.0150100

IF: 3.7

2016-03-14

PLoS ONE

Abstract:INTRODUCTION: Live attenuated oral vaccines against rotavirus (RV) have been shown to be less efficacious in children from developing countries. Reasons for this disparity are not fully understood. We assessed the role of maternal factors including breast milk RV-specific IgA, transplacentally acquired infant serum RV-specific IgG and maternal HIV status in seroconversion among Zambian infants routinely immunized with Rotarix™ (RV1).METHODS: 420 mother-child pairs were recruited at infant age 6-12 weeks in Lusaka. Clinical information and samples were collected at baseline and at one month following the second dose of RV1. Determination of breast milk RV-specific IgA and serum RV-specific IgA and IgG was done using standardized ELISA. Seroconversion was defined as a ≥ 4 fold rise in serum IgA titre from baseline to one-month post RV1 dose 2, while seropositivity of IgA was defined as serum titre ≥ 40 and antibody variables were modelled on log-base 2. Logistic regression was used to identify predictors of the odds of seroconversion.RESULTS: Baseline infant seropositivity was 25.5% (91/357). The seroconversion frequency was 60.2% (130/216). Infants who were IgA seropositive at baseline were less likely to seroconvert compared to their seronegative counterparts (P = 0.04). There was no evidence of an association between maternal HIV status and seroconversion (P = 0.25). Higher titres of breast milk rotavirus-specific IgA were associated with a lower frequency of seroconverson (Nonparametric test for trend Z = -2.84; P<0.01): a two-fold increase in breast milk RV-specific IgA titres was associated with a 22% lower odds of seroconversion (OR = 0.80; 95% CI = 0.68-0.94; P = 0.01). There was seasonal variation in baseline breast milk rotavirus-specific IgA titres, with significantly higher GMTs during the cold dry months (P = 0.01).CONCLUSION: Low immunogenicity of RV1 vaccine could be explained in part by exposure to high antibody titres in breast milk and early exposure to wild-type rotavirus infections. Potential interference of anti-RV specific IgA in breast milk and pre-vaccination serum RV specific-IgA and IgG titres with RV1 seroconversion and effectiveness requires further research.

multidisciplinary sciences
Learning from low income countries: what are the lessons?: Communities should decide priorities

P. Eunson

DOI: https://doi.org/10.1136/bmj.329.7475.1183

2004-11-11

British Medical Journal

Abstract:EDITOR—Women and children continue to die needlessly in developing countries. We know the causes but seem powerless to prevent their deaths. Constraints within health systems are blocking improvements, and we don't know enough about how to strengthen and sustain them without external investment. Individuals and communities have their own priorities for health, and a global solution for disease and poverty is impossible to prescribe. A village was asked by an aid agency what its priorities for development aid would be, the answer presumed to be a health …
916. the Transfer of Maternal Antibodies and Dynamics of Maternal and Natural Infection-induced Antibodies Against RSV in Children: A Longitudinal Cohort Study

Qianli Wang,Meng Xu,Yan Wang,Hongjie Yu

DOI: https://doi.org/10.1093/ofid/ofad500.961

2023-01-01

Open Forum Infectious Diseases

Abstract:Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infectious disease in children globally. Transplacental-acquired antibodies are essential in protecting infants during the initial months of their life. This study assessed the efficacy of transferring maternal RSV prefusion protein (pre-F) IgG antibodies via the placenta and reported the dynamics of maternal and natural infection-induced antibodies in children. Methods A longitudinal mother-neonate pairs cohort was started enrolled in southern China in the autumn of 2013. 660 mother-neonate pairs were included in this study. Both cord blood from neonates and venous blood from mothers at delivery were obtained. The children were followed up and blood samples were collected at ages 2, 4, 6, 12, 24, and 36 months, as well as at 6-8 years (Figure 1). RSV-specific pre-F IgG antibodies were identified by the enzyme-linked immunosorbent assay method. The maternal antibody transfer efficacy, decay of maternal antibodies, age-specific antibody level, and seroprevalence were estimated. Results All neonates acquired RSV pre-F IgG antibodies from their mothers. We found a significant correlation between maternal and neonatal antibody titers (ρ=0.86, P< 0.001). The average RSV pre-F IgG antibody titers were higher in cord blood than in maternal blood, with a mean transfer ratio of maternal antibodies of 1.48 (95%CI: 1.44-1.52) (Figure 2). Maternal antibody levels in neonates declined rapidly, with a half-life of 1.4 months. The lowest point of antibodies occurred at 11 months of age, followed by titer increases due to natural RSV infection, and approximately 50% of the children seroconverted at the age of 41.5 months.Figure 2(A) Correlation between neonatal and maternal antibody titer. (B) Transfer ratio with maternal antibody titers. The top orange density plots maternal antibody titers, and the right plots neonatal antibody titers. Conclusion Efficient transfer of RSV maternal antibodies to neonates was observed. As maternal antibodies wane, the seropositive infants gradually reduce to the lowest in the first year of life. After that, the infant’s immune system develops and naturally acquired immunity due to infection. Our findings will optimize future strategies for both vaccine and long-term prophylactic monoclonal antibodies to target RSV pre-F protein. Disclosures Hongjie Yu, PhD, GlaxoSmithKline: Grant/Research Support|Roche: Grant/Research Support|Sanofi: Grant/Research Support|SINOVAC: Grant/Research Support
The incidence of infants with rotavirus enteritis combined with lactose intolerance

Yulian Hu,Linyan Gui,Jing Chang,Jingyan Liu,Shuling Xu,Caiyan Deng,Fengqin Yu,Zhanmin Ma,Guangzhou Wang,Changjun Zhang

Abstract:This study was to research the incidence of infants with rotavirus enteritis combined with lactose intolerance and the clinical effect of low lactose milk powder for infantile rotavirus enteritis with lactose intolerance. The control groups were 126 cases of infants with diarrhea randomly collected from our hospital at the same period, which their rotavirus detection was negative. The observation group was 185 cases of infants with rotavirus, which was tested to be positive. Through the urine galactose determination, 62 cases of the control group were positive and 124 cases of the observation group were positive. Then 124 cases of infants with rotavirus combined with lactose intolerance were randomly divided into two groups. 60 cases in the control group were given rehydration, correction of acidosis, oral smecta, Intestinal probiotics and other conventional treatment, then continued to the original feeding method. While, 64 cases in the treatment group, on the basis of routine treatment, applied the low lactose milk feeding. To observe the total effective rate for the two groups. The incidence of lactose intolerance in children with rotavirus enteritis (67.03%) was significantly higher than that of children with diarrhea (49.2%), which was tested to be negative. And the difference was statistically significant (p<0.5). In the aspect of reducing the frequency of diarrhea, and diarrhea stool forming time, the treatment group has the obvious superiority. The total effective rate was 95.4% for treatment group, which was higher than that in the control group (76.7%), the difference was statistically significant (P<0.05). Conclusion: Infants with rotavirus enteritis was easier to merge with lactose intolerance. The low lactose milk powder could improve the therapeutic effectively and could reduce the duration of disease, and restored to normal diet for 2 weeks feeding time.
Effect of Anti-Rv Immunoglobulin Therapy on Infants with Rotavirus Enteritis

金玉,董巧丽,李宇宁,薛君莉,余唯琪,李玉梅,林丽星,王育哲

DOI: https://doi.org/10.3760/cma.j.issn.1673-4912.2004.06.008

2004-01-01

Abstract:Objective To evaluate effect and safety of oral anti-RV immunoglobulin of hens egg yolk IgY therapy on infants with rotavirus enteritis.Methods 214 infants with rotavirus enteritis were randomly divided into three groups.72 infants were received Anti-RV (IgY)in the treatment group.56 infants were received Anti-RV IgY and Smecta in the objective group.86 infants were received routine medicine in the control group.All the patients were received the same supporting therapy.Oral rehydration solution and/or venous infusion were used to correct water electrolyte balance if there was dehydration.Results The total effective rate in the group A was 77.8% and significantly higher than the group C (50.0% P0.01).The total effective rate in the group B was 80.4%,compared with the group A no significant differences (P0.05).Conclusion Anti-RV (IgY) is effective,safe and convenient for infantile rotavirus enteritis.Combined with Smecta was effective for treating infants with rotavirus enteritis and should be recommended anti-RV-IgG.
Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review

Hlaing Myat Thu,Theingi Win Myat,Mo Mo Win,Kyaw Zin Thant,Shofiqur Rahman,Kouji Umeda,Sa Van Nguyen,Faustino C. Jr. Icatlo,Kyoko Higo-Moriguchi,Koki Taniguchi,Takao Tsuji,Keiji Oguma,Sang Jong Kim,Hyun Suk Bae,Hyuk Joon Choi

DOI: https://doi.org/10.5851/kosfa.2017.37.1.1

2017-02-28

Korean Journal for Food Science of Animal Resources

Abstract:The rotavirus-induced diarrhea of human and animal neonates is a major public health concern worldwide. Until recently, no effective therapy is available to specifically inactivate the rotavirion particles within the gut. Passive immunotherapy by oral administration of chicken egg yolk antibody (IgY) has emerged of late as a fresh alternative strategy to control infectious diseases of the alimentary tract and has been applied in the treatment of diarrhea due to rotavirus infection. The purpose of this concise review is to evaluate evidence on the properties and performance of anti-rotavirus immunoglobulin Y (IgY) for prevention and treatment of rotavirus diarrhea in human and animal neonates. A survey of relevant anti-rotavirus IgY basic studies and clinical trials among neonatal animals (since 1994-2015) and humans (since 1982-2015) have been reviewed and briefly summarized. Our analysis of a number of rotavirus investigations involving animal and human clinical trials revealed that anti-rotavirus IgY significantly reduced the severity of clinical manifestation of diarrhea among IgY-treated subjects relative to a corresponding control or placebo group. The accumulated information as a whole depicts oral IgY to be a safe and efficacious option for treatment of rotavirus diarrhea in neonates. There is however a clear need for more randomized, placebo controlled and double-blind trials with bigger sample size to further solidify and confirm claims of efficacy and safety in controlling diarrhea caused by rotavirus infection especially among human infants with health issues such as low birth weights or compromised immunity in whom it is most needed.

Integrative Weaning Index: A Few Observations

Cord blood and breast-milk antibodies in neonatal rotavirus infection

Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors

Pyrin Levels in Human Monocytes and Monocyte-Derived Macrophages Regulate IL-1β Processing and Release1

Neutralizing activity and secretory IgA antibodies reactive with rotavirus SA-11 (serotype G3) in colostrum and milk from Brazilian women

Rotavirus infections in young Nicaraguan children

Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies.

Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi

Viraemia and Extraintestinal Involvement after Rotavirus Infection

Acetylcholinesterase inhibitors: a patent review (2008 – present)

Maternal immunity protects offspring from enteric viral infection without negatively affecting humoral immune memory

Rotavirus C: prevalence in suckling piglets and development of virus-like particles to assess the influence of maternal immunity on the disease development

Bifidobacterium breve M-16 V and scGOS/lcFOS Supplementation to Dams Ameliorates Infant Rotavirus Infection in Early Life

Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection

The Epidemiology of Rotavirus Infections

Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants

Learning from low income countries: what are the lessons?: Communities should decide priorities

916. the Transfer of Maternal Antibodies and Dynamics of Maternal and Natural Infection-induced Antibodies Against RSV in Children: A Longitudinal Cohort Study

The incidence of infants with rotavirus enteritis combined with lactose intolerance

Effect of Anti-Rv Immunoglobulin Therapy on Infants with Rotavirus Enteritis

Chicken Egg Yolk Antibodies (IgY) for Prophylaxis and Treatment of Rotavirus Diarrhea in Human and Animal Neonates: A Concise Review